Renal denervation for hypertension treatment: what has happened in 2015 and where to go next?

Summary

What lessons did we learn about hypertension in 2015? A. Pathak, F. Mahfoud and K. Tsioufis explore recent and ongoing trials in the treatment of hypertension: Are the guidelines changing? How is our understanding of the agents used in first-line treatment of resistant hypertension evolving? For interventional cardiologists, what are the emerging evidence concerning renal denervation that will cast light on its further use, such as a more profound understanding of renal nerve fibres? How will this affect your practice today and in the future? Join us!